United States · FDA National Drug Code directory
arformoterol tartrate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-168_07b162cc-b71c-4750-a10b-2db80625012f
- Product NDC
- 69097-168
- Form
- SOLUTION
- Composition / generic term
- arformoterol tartrate
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210622
- Source listing expiry
- 20261231
Source-listed ingredients
- ARFORMOTEROL TARTRATE — 15 ug/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 POUCH in 1 CARTON (69097-168-53) / 1 VIAL, SINGLE-DOSE in 1 POUCH (69097-168-32) / 2 mL in 1 VIAL, SINGLE-DOSE · 69097-168-53
- 12 POUCH in 1 CARTON (69097-168-64) / 5 VIAL, SINGLE-DOSE in 1 POUCH / 2 mL in 1 VIAL, SINGLE-DOSE · 69097-168-64
- 6 POUCH in 1 CARTON (69097-168-87) / 5 VIAL, SINGLE-DOSE in 1 POUCH (69097-168-48) / 2 mL in 1 VIAL, SINGLE-DOSE · 69097-168-87
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →